CLINICAL_TRIALS
trial_result
· 2021-08-09
Clinical Trial Update: Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine [Phase 4]
Summary
Phase 4 head-to-head trial comparing erenumab to topiramate in episodic and chronic migraine completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2021-08-09